Xeptiva Therapeutics

  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trials
    • Chronic Pain
    • Atopic Dermatitis
  • News
    • See news
    • Press
  • Blog
  • Contact
  • Home
  • Company
    • About us
    • Team
  • Innovation
    • Technology
    • Pipeline
    • Target diseases
  • Clinical Trials
    • Chronic Pain
    • Atopic Dermatitis
  • News
    • See news
    • Press
  • Blog
  • Contact

​New agreement between
​xeptiva therapeutics and
​ institut pasteur de montevideo

december 22, 2023
read below
Picture

On December 21, 2023, Xeptiva signed an agreement with the Institut Pasteur de Montevideo, making them a new partner of Xeptiva. This marks a major milestone in driving development of our technology, advancing the company’s growth and attracting private capital.
​

The Institut Pasteur de Montevideo is an institution dedicated to scientific research in biological medicine, consisting of high-tech scientific platforms, laboratories, international teaching center, and startups for the development of biotechnological applications. 

​
We are very excited about this collaboration that will allow us to bring our technology to the market.

Read the full press release here

COMPANY

About Us
Team

INNOVATION

Technology
Pipeline
Target diseases

clinical trial

NEWS

See News
Press releases

cONTACT

BLOG

© COPYRIGHT 2025.  ALL RIGHTS RESERVED.